Literature DB >> 7816766

Distribution kinetics of salicylic acid in the isolated perfused rat liver assessed using moment analysis and the two-compartment axial dispersion model.

Z Hussein1, A J McLachlan, M Rowland.   

Abstract

The distribution kinetics of salicylic acid in the single-pass isolated perfused rat liver has been investigated under varying conditions of perfusate flow (15 to 30 ml min-1) and of salicylate perfusate concentration (0, 100, 200 mg l-1) using statistical moment analysis and the two-compartment axial dispersion model. Salicylic acid was not metabolised during the experiment. The perfusate did not contain binding protein. As flow rate was increased, the maximum fraction output per second (f(t)max) increased and the mean transit time (MTTH) decreased, while tmax became shorter for both tritiated water and 14C-salicylic acid. Increasing the salicylate perfusate concentration profoundly affected the frequency outflow profile of 14C-salicylic acid, but not that of tritiated water. The one-compartment axial dispersion model adequately described the frequency outflow profile for tritiated water, whereas the two-compartment form, which incorporates a cellular permeability barrier, provided a better description of the 14C-salicylic acid outflow data. The estimated two-compartment axial dispersion model parameters for 14C-salicylic acid, DN, the dispersion number (0.08 +/- 0.03), k12, the influx rate constant (0.56 +/- 0.04 sec-1) and k21, the efflux rate constant (0.095 +/- 0.01 sec-1) were independent of perfusate flow rate. The in situ permeability-surface area product for 14C-salicylic acid (4.6 +/- 0.7 ml min-1g-1 liver) was in good agreement with literature estimates obtained from in vitro hepatocyte experiments, suggesting that the permeability barrier is at the hepatocyte membrane. Whereas DN and k12 were uninfluenced by, k21 displayed a positive correlation with, salicylate perfusate concentration. This correlation was most likely due to decreased intracellular salicylate binding.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7816766     DOI: 10.1023/a:1018958915171

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  19 in total

1.  Residence time distributions of solutes in the perfused rat liver using a dispersion model of hepatic elimination: 1. Effect of changes in perfusate flow and albumin concentration on sucrose and taurocholate.

Authors:  M S Roberts; S Fraser; A Wagner; L McLeod
Journal:  J Pharmacokinet Biopharm       Date:  1990-06

2.  A two-compartment dispersion model describes the hepatic outflow profile of diclofenac in the presence of its binding protein.

Authors:  A M Evans; Z Hussein; M Rowland
Journal:  J Pharm Pharmacol       Date:  1991-10       Impact factor: 3.765

3.  Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).

Authors:  Y Yano; K Yamaoka; Y Aoyama; H Tanaka
Journal:  J Pharmacokinet Biopharm       Date:  1989-04

4.  A dispersion model of hepatic elimination: 1. Formulation of the model and bolus considerations.

Authors:  M S Roberts; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1986-06

5.  Simultaneous liquid-chromatographic quantitation of salicylic acid, salicyluric acid, and gentisic acid in plasma.

Authors:  B E Cham; D Johns; F Bochner; D M Imhoff; M Rowland
Journal:  Clin Chem       Date:  1979-08       Impact factor: 8.327

6.  Effect of perfusion rate on the local disposition of cefixime in liver perfusion system based on two-compartment dispersion model.

Authors:  Y Yano; K Yamaoka; H Yasui; T Nakagawa
Journal:  Drug Metab Dispos       Date:  1991 Nov-Dec       Impact factor: 3.922

7.  Influence of albumin on the distribution and elimination kinetics of diclofenac in the isolated perfused rat liver: analysis by the impulse-response technique and the dispersion model.

Authors:  A M Evans; Z Hussein; M Rowland
Journal:  J Pharm Sci       Date:  1993-04       Impact factor: 3.534

8.  Kinetic interpretation of hepatic multiple-indicator dilution studies.

Authors:  C A Goresky
Journal:  Am J Physiol       Date:  1983-07

9.  Protein binding and hepatic clearance: discrimination between models of hepatic clearance with diazepam, a drug of high intrinsic clearance, in the isolated perfused rat liver preparation.

Authors:  M Rowland; D Leitch; G Fleming; B Smith
Journal:  J Pharmacokinet Biopharm       Date:  1984-04

10.  Application of the axial dispersion model of hepatic drug elimination to the kinetics of diazepam in the isolated perfused rat liver.

Authors:  J M Díaz-García; A M Evans; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1992-04
View more
  8 in total

1.  Modeling of hepatic elimination and organ distribution kinetics with the extended convection-dispersion model.

Authors:  M S Roberts; Y G Anissimov
Journal:  J Pharmacokinet Biopharm       Date:  1999-08

2.  Analysis of nonlinear hepatic clearance of a cyclopentapeptide, BQ-123, with the multiple indicator dilution method using the dispersion model.

Authors:  A Hisaka; T Nakamura; Y Sugiyama
Journal:  Pharm Res       Date:  1999-01       Impact factor: 4.200

3.  Metabolite mean transit times in the liver as predicted by various models of hepatic elimination.

Authors:  G D Mellick; Y G Anissimov; A J Bracken; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

4.  A physiologically based pharmacokinetic model incorporating dispersion principles to describe solute distribution in the perfused rat hindlimb preparation.

Authors:  R E Oliver; A C Heatherington; A F Jones; M Rowland
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

5.  Tissue distribution kinetics as determinant of transit time dispersion of drugs in organs: application of a stochastic model to the rat hindlimb.

Authors:  M Weiss; M S Roberts
Journal:  J Pharmacokinet Biopharm       Date:  1996-04

6.  Cytoplasmic binding and disposition kinetics of diclofenac in the isolated perfused rat liver.

Authors:  M Weiss; O Kuhlmann; D Y Hung; M S Roberts
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

7.  Stereoselective hepatic disposition of model diastereomeric acyl glucuronides.

Authors:  David M Shackleford; Roger L Nation; R W Milne; P J Hayball; Allan M Evans
Journal:  J Pharmacokinet Pharmacodyn       Date:  2004-02       Impact factor: 2.745

Review 8.  Drug structure-transport relationships.

Authors:  Michael S Roberts
Journal:  J Pharmacokinet Pharmacodyn       Date:  2010-11-24       Impact factor: 2.745

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.